Diagnosis of Langergans' cell histiocytosis (retrospective analysis of 70 cases) Source: Eur Respir J 2003; 22: Suppl. 45, 43s Year: 2003
Lung involvement in childhood Langerhans cell histiocytosis, A multi-institutional study from the french LCH study group Source: International Congress 2019 – Granulomatous disorders: from bench to bedside Year: 2019
Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008
Pulmonary Langerhans‘ cell histiocytosis (PLCH): A new UK register Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012
Clinical and pathological features of 13 adult patients with pulmonary Langerhans‘ cell histiocytosis Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009
Imaging of pulmonary histiocytosis X , report of 10 cases Source: Eur Respir J 2004; 24: Suppl. 48, 489s Year: 2004
The proteomic analysis of BAL from patients with langerhans cell histiocytosis (LCH) Source: Eur Respir J 2007; 30: Suppl. 51, 245s Year: 2007
Pneumothorax in pulmonary langerhans cell histiocytosis (PLCH) Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018
Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019
Chemotherapy in patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018
Pulmonary resection for renal cell carcinoma metastases: a retrospective analysis of 21 patients Source: Eur Respir J 2007; 30: Suppl. 51, 465s Year: 2007
Diagnosis, treatment and outcome of pulmonary neuroendocrine tumors (PNT) - a review of 104 cases Source: Eur Respir J 2002; 20: Suppl. 38, 270s Year: 2002
Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019
The long-term outcome of adult pulmonary Langerhans cell histiocytosis: a national registry-based prospective cohort study Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases Year: 2020
Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012
Sarcoidosis and malignancy. Retrospective study of 6 clinical cases and literature review Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases Year: 2010
The treatment of a non-Largenhans-cell histiocytosis, Erdheim-Chester disease: A-case report Source: Annual Congress 2012 - The good clinical practice: useful case report Year: 2012
LAM, sarcoidosis, histiocytosis X – rare indications for lung transplantation – a single center experience Source: Eur Respir J 2007; 30: Suppl. 51, 175s Year: 2007
Pneumothorax in patients with Langerhans cell histiocytosis Source: International Congress 2017 – The acute patient: the clinical point-of-view Year: 2017
Langerhans cell histiocytosis: is it an ILD? Source: Virtual Congress 2021 – Interstitial lung diseases Year: 2021